Medically reviewed by Uri Gedalia, MD, FACS
Chief Medical Officer, TrufaMED Urgent Care & Concierge Medicine
Board-Certified, General Surgery
Last reviewed: October 2026
The NAD+ supplement market has exploded over the last five years. NAD+ IV therapy, NR (nicotinamide riboside, sold as Niagen), and NMN (nicotinamide mononucleotide) are sold side-by-side as longevity supplements with overlapping marketing claims. They are not the same compound and the evidence supporting each is different.
This post sorts out what each one actually is, what the research supports, what regulatory changes have happened to NMN, and what we recommend in 2026.
The Biology In One Paragraph
NAD+ (nicotinamide adenine dinucleotide) is the active cofactor your cells use. Direct NAD+ supplementation in oral form is poorly absorbed because NAD+ gets broken down before it can be used. The supplement industry uses precursors — molecules your body can convert to NAD+ — instead. NR and NMN are two of these precursors. They differ in their position in the conversion pathway and in their pharmacokinetics.
NR (Niagen / Nicotinamide Riboside)
NR is the most-researched NAD+ precursor with multiple published human trials. It is sold over-the-counter as a dietary supplement (brand name Niagen and others). Doses in human trials have ranged from 250 mg to 1,000 mg daily.
What the research supports:
- Raises blood NAD+ levels meaningfully (typically 40 to 60% above baseline at 300 to 1,000 mg/day)
- Generally well-tolerated; few significant side effects in published trials
- Some evidence of cardiovascular markers improvement, exercise recovery effects, and metabolic markers in specific populations
- Patent-protected and well-supplied as a research-grade supplement
Limitations: human trials of clinical endpoints (lifespan, disease prevention) are not yet available. Subjective benefits in healthy adults are variable. Cost is meaningful at $50 to $100 per month for therapeutic doses.
NMN (Nicotinamide Mononucleotide)
NMN sits one step further along the NAD+ pathway than NR. It became wildly popular through advocacy by David Sinclair and others, with strong animal data and promising early human data. In late 2022 the FDA stated NMN is not a dietary supplement (because it had been studied as a drug), creating regulatory ambiguity that continues.
Current status in 2026: NMN remains widely available from supplement retailers, but the regulatory status is not fully resolved. Quality and purity vary significantly across brands. Some clinicians have moved away from recommending NMN to patients given the uncertainty.
What the research supports: similar pharmacokinetic effect to NR, possibly more efficient at raising NAD+ at equivalent dose. Animal data is favorable. Human disease-endpoint data is limited.
NAD+ IV Therapy
IV NAD+ bypasses the precursor pathway and delivers NAD+ directly to circulation. The peak NAD+ levels achieved are much higher than oral precursors can reach. The pharmacokinetic case is strong; the practical question is whether transient high peaks produce different clinical effects than steady oral elevation.
We covered IV NAD+ in detail in our NAD+ IV therapy post. Cost at our clinic is $1,000 per session for a 500 mg slow infusion.
Which Should You Choose
Our current thinking for adults interested in NAD+ supplementation:
- NR oral: Most defensible choice for daily supplementation. Strong supplement-tier safety record, well-researched, clear regulatory status, predictable cost. Dose 300 to 1,000 mg/day.
- NMN oral: Reasonable choice from a known-quality supplier; regulatory ambiguity is the consideration. Some patients prefer NMN based on the animal data. Dose 500 to 1,000 mg/day.
- IV NAD+: Best for periodic high-dose boosting (pre-event, recovery, longevity exploration). Not a daily intervention. Dose typically 500 to 1,000 mg per infusion.
- Niacin (vitamin B3): A cheaper precursor with longer history. Less elegant than NR or NMN, but it works. Use the flush-free form if tolerability matters.
- Niacinamide: The most-researched form for vitamin deficiency replacement; cheap. Not as effective at raising NAD+ as NR or NMN at supplement doses.
Stacking
Common reasonable combinations:
- Daily oral NR for ongoing supplementation, plus periodic IV NAD+ before high-stress periods or for cognitive recovery
- Daily oral NR combined with trimethylglycine (TMG) to provide methyl donors that some NAD+ pathways consume
- Pterostilbene (a sirtuin activator related to resveratrol) is sometimes co-marketed with NR; the combination evidence is weaker than NR alone
What Are The Likely Effects
Subjective effects most patients report:
- Slightly improved energy or alertness, particularly with consistent daily oral supplementation
- Better post-exercise recovery in athletic adults
- Possible improvement in metabolic markers over months
What is unproven: lifespan extension in humans, prevention of specific diseases, cognitive enhancement in healthy adults. We do not promise these effects.
Frequently Asked Questions
Should I take NR or NMN?
NR has the stronger regulatory status and human research base. NMN remains widely available but has regulatory uncertainty. Either is reasonable from a quality source.
Is IV NAD+ better than oral?
Different. IV produces a high transient peak; oral produces a steady rise. Many longevity-focused adults do both.
Will NAD+ supplements make me live longer?
Honest answer: we do not know. The animal data is suggestive; human lifespan data is not available. Most adults supplement for subjective effects and prudent investment in cellular metabolism.
Are there risks?
Oral NR and NMN at recommended doses are well-tolerated in published trials. IV NAD+ requires physician supervision but is well-tolerated when properly delivered. Specific contraindications: active malignancy is a relative caution given unclear interactions with cancer biology.
